Limit search to available items
Book Cover
E-book

Title Medications for opioid use disorder save lives / Committee on Medication-Assisted Treatment for Opioid Use Disorder ; Alan I. Leshner and Michelle Mancher, editors ; Board on Health Sciences Policy, Health and Medicine Division
Published Washington, DC : National Academies Press, [2019]

Copies

Description 1 online resource (1 PDF file (xviii, 156 pages)) : illustrations, maps
Series Consensus study report of the National Academies of Sciences, Engineering, Medicine
Consensus study report.
Contents Introduction -- The effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder -- Appendixes
Summary The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed
Bibliography Includes bibliographical references
Notes This activity was supported by a contract between the National Academy of Sciences and the National Institutes of Health (HHSN263201800029I/HHSN26300005) and the Substance Abuse and Mental Health Services Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project
Online resource; title from PDF title page (viewed August 23, 2019)
Subject Opioid abuse -- Treatment -- United States
Drug addicts -- Rehabilitation -- United States
Opioids -- Overdose -- Treatment -- United States
Brain -- Diseases -- Treatment -- United States
Opioid abuse -- Prevention -- Government policy
Methadone maintenance -- United States
Buprenorphine -- Therapeutic use -- United States
Naloxone -- Therapeutic use -- United States
Naltrexone -- Therapeutic use -- United States
Drugs -- Overdose.
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Users
Drug Overdose
Drugs -- Overdose
Brain -- Diseases -- Treatment
Buprenorphine -- Therapeutic use
Drug addicts -- Rehabilitation
Methadone maintenance
Opioid abuse -- Treatment
United States
United States
Form Electronic book
Author Mancher, Michelle, editor
Leshner, Alan I., 1944- editor.
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Medication-Assisted Treatment for Opioid Use Disorder, issuing body.
ISBN 9780309486514
0309486513